XML 41 R32.htm IDEA: XBRL DOCUMENT v3.7.0.1
Business Segment and Geographical Information (Tables)
 12 Months Ended
Dec. 31, 2016
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Business Segment Information
(In millions)
 
2016

 
2015

 
2014

 
 
 
 
 
 
 
Revenues
 
 
 
 
 
 
Life Sciences Solutions
 
$
5,317.2

 
$
4,774.3

 
$
4,532.7

Analytical Instruments
 
3,668.2

 
3,208.2

 
3,252.2

Specialty Diagnostics
 
3,339.2

 
3,243.9

 
3,343.6

Laboratory Products and Services
 
6,723.6

 
6,371.7

 
6,311.6

Eliminations
 
(774.1
)
 
(632.7
)
 
(550.5
)
 
 
 
 
 
 
 
Consolidated revenues
 
18,274.1

 
16,965.4

 
16,889.6

 
 
 
 
 
 
 
Segment Income (a)
 
 
 
 
 
 
Life Sciences Solutions
 
1,595.5

 
1,413.7

 
1,283.6

Analytical Instruments
 
745.2

 
612.8

 
581.1

Specialty Diagnostics
 
909.8

 
872.9

 
916.0

Laboratory Products and Services
 
971.3

 
922.3

 
914.1

 
 
 
 
 
 
 
Subtotal reportable segments (a)
 
4,221.8

 
3,821.7

 
3,694.8

 
 
 
 
 
 
 
Cost of revenues charges
 
(101.5
)
 
(9.1
)
 
(327.6
)
Selling, general and administrative charges, net
 
(103.9
)
 
(46.3
)
 
(130.7
)
Restructuring and other (costs) income, net
 
(189.2
)
 
(115.3
)
 
598.2

Amortization of acquisition-related intangible assets
 
(1,378.0
)
 
(1,314.8
)
 
(1,331.7
)
 
 
 
 
 
 
 
Consolidated operating income
 
2,449.2

 
2,336.2

 
2,503.0

Other expense, net (b)
 
(425.3
)
 
(399.8
)
 
(415.8
)
 
 
 
 
 
 
 
Income from continuing operations before income taxes
 
$
2,023.9

 
$
1,936.4

 
$
2,087.2

 
 
 
 
 
 
 
Depreciation
 
 
 
 
 
 
Life Sciences Solutions
 
$
142.3

 
$
147.5

 
$
132.7

Analytical Instruments
 
49.7

 
38.9

 
39.0

Specialty Diagnostics
 
70.4

 
73.7

 
76.7

Laboratory Products and Services
 
117.6

 
113.3

 
104.7

 
 
 
 
 
 
 
Consolidated depreciation
 
$
380.0

 
$
373.4

 
$
353.1

(a)
Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)
The company does not allocate other expense, net to its segments.
(In millions)
 
2016

 
2015

 
2014

 
 
 
 
 
 
 
Total Assets
 
 
 
 
 
 
Life Sciences Solutions
 
$
19,065.2

 
$
18,537.3

 
$
19,918.3

Analytical Instruments
 
9,519.6

 
4,763.1

 
4,133.3

Specialty Diagnostics
 
6,801.6

 
7,183.2

 
8,047.7

Laboratory Products and Services
 
9,405.4

 
9,613.6

 
10,214.4

Corporate/Other (c)
 
1,115.7

 
737.1

 
538.4

 
 
 
 
 
 
 
Consolidated total assets
 
$
45,907.5

 
$
40,834.3

 
$
42,852.1

 
 
 
 
 
 
 
Capital Expenditures
 
 
 
 
 
 
Life Sciences Solutions
 
$
122.3

 
$
93.2

 
$
114.4

Analytical Instruments
 
34.0

 
59.5

 
38.1

Specialty Diagnostics
 
72.3

 
75.9

 
84.7

Laboratory Products and Services
 
111.2

 
89.6

 
92.1

Corporate/Other
 
104.6

 
104.7

 
98.3

 
 
 
 
 
 
 
Consolidated capital expenditures
 
$
444.4

 
$
422.9

 
$
427.6

(c)
Corporate assets consist primarily of cash and cash equivalents, short-term investments, property and equipment at the company's corporate offices.
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Business Segment Information
(In millions)
 
2016

 
2015

 
2014

 
 
 
 
 
 
 
Revenues
 
 
 
 
 
 
Life Sciences Solutions
 
$
5,317.2

 
$
4,774.3

 
$
4,532.7

Analytical Instruments
 
3,668.2

 
3,208.2

 
3,252.2

Specialty Diagnostics
 
3,339.2

 
3,243.9

 
3,343.6

Laboratory Products and Services
 
6,723.6

 
6,371.7

 
6,311.6

Eliminations
 
(774.1
)
 
(632.7
)
 
(550.5
)
 
 
 
 
 
 
 
Consolidated revenues
 
18,274.1

 
16,965.4

 
16,889.6

 
 
 
 
 
 
 
Segment Income (a)
 
 
 
 
 
 
Life Sciences Solutions
 
1,595.5

 
1,413.7

 
1,283.6

Analytical Instruments
 
745.2

 
612.8

 
581.1

Specialty Diagnostics
 
909.8

 
872.9

 
916.0

Laboratory Products and Services
 
971.3

 
922.3

 
914.1

 
 
 
 
 
 
 
Subtotal reportable segments (a)
 
4,221.8

 
3,821.7

 
3,694.8

 
 
 
 
 
 
 
Cost of revenues charges
 
(101.5
)
 
(9.1
)
 
(327.6
)
Selling, general and administrative charges, net
 
(103.9
)
 
(46.3
)
 
(130.7
)
Restructuring and other (costs) income, net
 
(189.2
)
 
(115.3
)
 
598.2

Amortization of acquisition-related intangible assets
 
(1,378.0
)
 
(1,314.8
)
 
(1,331.7
)
 
 
 
 
 
 
 
Consolidated operating income
 
2,449.2

 
2,336.2

 
2,503.0

Other expense, net (b)
 
(425.3
)
 
(399.8
)
 
(415.8
)
 
 
 
 
 
 
 
Income from continuing operations before income taxes
 
$
2,023.9

 
$
1,936.4

 
$
2,087.2

 
 
 
 
 
 
 
Depreciation
 
 
 
 
 
 
Life Sciences Solutions
 
$
142.3

 
$
147.5

 
$
132.7

Analytical Instruments
 
49.7

 
38.9

 
39.0

Specialty Diagnostics
 
70.4

 
73.7

 
76.7

Laboratory Products and Services
 
117.6

 
113.3

 
104.7

 
 
 
 
 
 
 
Consolidated depreciation
 
$
380.0

 
$
373.4

 
$
353.1

(a)
Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)
The company does not allocate other expense, net to its segments.
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
(In millions)
 
2016

 
2015

 
2014

 
 
 
 
 
 
 
Revenues (d)
 
 
 
 
 
 
United States
 
$
9,085.6

 
$
8,607.3

 
$
8,147.7

China
 
1,729.6

 
1,376.4

 
1,223.1

Germany
 
995.8

 
899.7

 
1,005.9

United Kingdom
 
742.2

 
778.1

 
754.5

Japan
 
737.3

 
611.1

 
672.8

Other
 
4,983.6

 
4,692.8

 
5,085.6

 
 
 
 
 
 
 
Consolidated revenues
 
$
18,274.1

 
$
16,965.4

 
$
16,889.6

 
 
 
 
 
 
 
Long-lived Assets (e)
 
 
 
 
 
 
United States
 
$
1,630.2

 
$
1,532.0

 
$
1,501.7

United Kingdom
 
216.8

 
261.1

 
265.5

Germany
 
157.6

 
169.4

 
170.3

Other
 
573.2

 
486.3

 
489.0

 
 
 
 
 
 
 
Consolidated long-lived assets
 
$
2,577.8

 
$
2,448.8

 
$
2,426.5

(d)
Revenues are attributed to countries based on customer location.
(e)
Includes property, plant and equipment, net.